Stryker (SYK) Tops Q1 EPS by 13c; Issues Strong Outlook

Stryker (NYSE: SYK) reported Q1 EPS of $2.14, $0.13 better than the analyst estimate of $2.01. Revenue for the quarter came in at $4.8 billion versus the consensus estimate of $4.56 billion.

GUIDANCE:

Stryker sees FY2023 EPS of $10.05-$10.25, versus the consensus of $10.06. They now expect full year 2023 organic net sales growth(2) to be in the range of 8.0% to 9.0%.

For earnings history and earnings-related data on Stryker (SYK) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Rivian raises 2026 delivery outlook after Q2 results top guidance